A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rat

 

Presented by Mary E. Klotman, MD, Dean, Duke University School of Medicine Part 1 [video:https://youtu.be/uNVbTY1guNM]

 

 

The second entry in our “Neurology and Men’s Health” series focuses on amyotrophic lateral sclerosis, or ALS.

Registration now open for SOM Faculty Registration will open to all others on June 25  

The Children’s Health & Discovery Initiative (CHDI) held a launch event on Thursday, May 31, 2018 at the Chesterfield Building in downtown Durham to highlight research into the p